The store will not work correctly when cookies are disabled.
2-(1,3-dimethyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-5-yl)-1H-benzo[de]isoquinoline-1,3(2H)-dione
ID: ALA4077619
PubChem CID: 4102773
Max Phase: Preclinical
Molecular Formula: C21H15N3O3
Molecular Weight: 357.37
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cn1c(=O)n(C)c2cc(N3C(=O)c4cccc5cccc(c45)C3=O)ccc21
Standard InChI: InChI=1S/C21H15N3O3/c1-22-16-10-9-13(11-17(16)23(2)21(22)27)24-19(25)14-7-3-5-12-6-4-8-15(18(12)14)20(24)26/h3-11H,1-2H3
Standard InChI Key: PKAHAABFUSYZKX-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 31 0 0 0 0 0 0 0 0999 V2000
15.0753 -17.9080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4932 -17.9044 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7805 -17.4950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0742 -18.7317 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3640 -19.1403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3647 -19.9619 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0816 -20.3731 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7822 -19.1406 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7823 -19.9549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4842 -20.3618 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1905 -19.9548 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.1904 -19.1405 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4841 -18.7333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8984 -20.3678 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8960 -21.1903 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6065 -21.5997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6072 -19.9565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3182 -20.3664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3228 -21.1916 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1092 -21.4410 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.5882 -20.7699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1019 -20.1042 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.9026 -18.7325 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.4832 -21.1831 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.3500 -19.3215 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3661 -22.2209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4095 -20.7653 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 4 2 0
13 2 1 0
2 3 2 0
3 1 1 0
8 4 1 0
4 5 1 0
5 6 2 0
6 7 1 0
7 9 2 0
8 9 1 0
8 13 2 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
14 15 2 0
15 16 1 0
16 19 2 0
18 17 2 0
17 14 1 0
11 14 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 18 1 0
12 23 2 0
10 24 2 0
22 25 1 0
20 26 1 0
21 27 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 357.37 | Molecular Weight (Monoisotopic): 357.1113 | AlogP: 2.83 | #Rotatable Bonds: 1 |
Polar Surface Area: 64.31 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 2.83 | CX LogD: 2.83 |
Aromatic Rings: 4 | Heavy Atoms: 27 | QED Weighted: 0.49 | Np Likeness Score: -1.03 |
References
1. Bouché L, Christ CD, Siegel S, Fernández-Montalván AE, Holton SJ, Fedorov O, Ter Laak A, Sugawara T, Stöckigt D, Tallant C, Bennett J, Monteiro O, Díaz-Sáez L, Siejka P, Meier J, Pütter V, Weiske J, Müller S, Huber KVM, Hartung IV, Haendler B.. (2017) Benzoisoquinolinediones as Potent and Selective Inhibitors of BRPF2 and TAF1/TAF1L Bromodomains., 60 (9): [PMID:28402630] [10.1021/acs.jmedchem.7b00306] |